Lav Leads $19M Series B Funding In Novlead Biotech

Nov 18, 2021•over 3 years ago

Amount Raised

$19 Million

Round Type

series b

Description

Medical devices maker Novlead Biotech announced on Tuesday that it has garnered 120 million yuan ($19 million) in a Series B round of financing led by the biomedical-focussed venture capital firm Lilly Asia Ventures (LAV).

Company Information

Company

Novlead Biotech

About

诺令生物致力于世界领先的医疗创新技术和定制化解决方案的提供。一氧化氮吸入技术和抗微生物新疗，高分子和创新的NO气体传输系统。

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Lav Leads $19M Series B Funding In Novlead Biotech

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information